Skip to main content

Halstead Michael's Form 4 filing

Intra-Cellular Therapies, Inc. (ITCI) · filed Mar 13, 2023

Accession no.
0001209191-23-018285
Filed
Mar 13, 2023
Trade date
Mar 9-13, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.05M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Halstead MichaelCIK 0001521548Officer (EVP and General Counsel)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 9, 2023Common StockAGrant or awardAcquired+16,708$0.00$016,708Direct
Mar 10, 2023Common StockSSaleDisposed−14,208$43.20−$613,785.62,500Direct
Mar 10, 2023Common StockSSaleDisposed−2,500$42.52−$106,3000Direct
Mar 10, 2023Common StockMOption exerciseAcquired+7,344––7,344Direct
Mar 13, 2023Common StockSSaleDisposed−6,868$44.99−$308,991.32476Direct
Mar 13, 2023Common StockSSaleDisposed−476$44.15−$21,015.40Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 10, 2023Common StockMOption exerciseDisposed−7,344$0.00$014,690Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)